Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-007817

Chairman and CEO bought 18,800 shares at an average $1.28 ($23,998)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2020-02-06 Purchase +13,800 $1.21 $16,698 10,301,693 D
Niihara Yutaka Chairman and CEO 2020-02-07 Purchase +5,000 $1.46 $7,300 10,306,693 D
Open-market purchases · 18,800 sh · avg $1.28 · $23,998
Loading xslF345X03/doc4.xml…